Transcripts Quince Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq 22:00:00 14/08/2026			Varia. 5j.	Varia. 1 janv.
34,04 ^USD	+5,03 %		+12,72 %	-94,92 %

14/08	Quince Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
29/07	Quince Therapeutics, Inc. : Oppenheimer optimiste sur le dossier	ZM

11/06	Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call
18/05	Transcript : Quince Therapeutics, Inc., OrphAI Therapeutics Inc - M&A Call
02/10/25	Transcript : Quince Therapeutics, Inc. - Analyst/Investor Day
24/09/25	Transcript : Quince Therapeutics, Inc. - Special Call
04/06/25	Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call
07/02/25	Transcript : Quince Therapeutics, Inc. - Special Call
26/06/24	Transcript : Quince Therapeutics, Inc. - Special Call
05/06/24	Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call
26/03/24	Transcript : Quince Therapeutics, Inc. - Special Call
24/05/23	Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call
26/10/21	Transcript : Cortexyme, Inc. - Special Call
13/09/21	Transcript : Cortexyme, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM
30/07/21	Transcript : Cortexyme, Inc. - Special Call
23/07/21	Transcript : Cortexyme, Inc. - Special Call
16/06/21	Transcript : Cortexyme, Inc. Presents at The JMP Securities Life Sciences Conference, Jun-16-2021 03:00 PM
02/06/21	Transcript : Cortexyme, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 02:00 PM
01/04/21	Transcript : Cortexyme, Inc. Presents at Stifel's 3rd Annual CNS Day, Apr-01-2021 10:00 AM
16/03/21	Transcript : Cortexyme, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 02:30 PM